Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Stock Information | RedChip

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Listen to this Section


$2.99
+0.4100 ( +15.89% ) 42.9K

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Market Data


Open


$2.99

Previous close


$2.58

Volume


42.9K

Market cap


$1.52M

Day range


$2.55 - $3.06

52 week range


$2.40 - $29.07

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 11, 2024
4 Insider transactions 1 Jun 10, 2024
8-k 8K-related 15 May 28, 2024
8-k 8K-related 18 May 17, 2024
10-q Quarterly Reports 48 May 09, 2024
8-k 8K-related 15 May 09, 2024
def Proxies and info statements 7 May 08, 2024
ars Annual reports 1 May 08, 2024
pre Proxies and info statements 7 Apr 22, 2024
8-k 8K-related 15 Apr 02, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.